Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR
Recruiting now · Not applicable
Conditions studied: Xerosis Cutis
In brief
Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated With Anti-EGFR.
Key facts
- Study ID
- NCT06868771
- Run by
- Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
- People needed
- 164
- Starts
- 2022-07-29
- Expected to finish
- 2025-04-30
- Last updated by the study team
- 2025-03-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients aged 18 who have been receiving anti-EGFR therapy for more than three months,
- signature of the informed consent.
You may not qualify if…
- Patients diagnosed with Grade II papulopustulous skin reaction according to the Common Terminology Criteria for Adverse Event (CTCAE) scale at the time of enrolment;
- concomitant use of emollients and/or steroidal creams;
- personal history of xerotic pathologies (e.g. lichen, ichthyosis) and/or itching of n.d.d.;
- inability to provide informed consent or inability to complete the procedures required for enrollment in the study.
Where it is running
- Irccs Fondazione Policlinico Gemelli — Roma, ROMA, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.